Clinical and Radiologic Outcomes of NOVOSIS (rhBMP‐2 With Hydroxyapatite Carrier) Grafting for Scaphoid Waist Nonunion: A Preliminary Clinical Study Authors: Jisu Park, Ki Youn Kwon, Hyung Joon Ahn, Jin‐Rok Oh Published: 2026 ABSTRACT ABSTRACTObjectiveScaphoid nonunion remains a challenging problem due to limited vascularity and carpal malalignment. Although autologous bone grafting remains the standard of care, donor‐site morbidity and technical demands can be substantial. NOVOSIS, a composite of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) and a hydroxyapatite (HA) carrier, has shown osteoinductive and osteoconductive potential in other orthopedic applications, but its clinical efficacy in scaphoid nonunion has not been established.MethodsSeven consecutive patients with scaphoid waist nonunion underwent fixation using two 2.3‐mm headless compression screws and NOVOSIS application between August 2023 and December 2024. All patients were followed for a minimum of 12 months (mean 12.4 months; range 12–14). Clinical outcomes were assessed using visual analogue scale (VAS), range of motion (ROM), and Mayo Wrist Score (MWS). Radiographic parameters included lateral intrascaphoid angle (LISA) and scapholunate angle (SLA). Paired t‐tests compared pre‐ and postoperative values.ResultsAll patients achieved radiographic union at final follow‐up. VAS scores improved from 4.9 ± 1.2 to 0.4 ± 0.8 (p < 0.001), and MWS from 59.3 ± 7.3 to 94.3 ± 5.4 (p < 0.001). LISA improved from 51.7° ± 13.6° to 31.5° ± 5.1° (p = 0.007), and SLA from 65.7° ± 6.8° to 52.2° ± 8.8° (p = 0.006). No procedure‐related complications, such as infection, ectopic bone formation, or donor‐site morbidity, were observed.ConclusionThis preliminary clinical series demonstrated that NOVOSIS provided reliable union, functional recovery, and radiographic correction in scaphoid nonunion without donor‐site morbidity. It may serve as a feasible alternative to autologous bone grafting and warrants further validation in larger studies.Keywords: bone graft substitute, hydroxyapatite, NOVOSIS, rhBMP‐2, scaphoid nonunion Introduction Among carpal injuries, fractures of the scaphoid are the most frequently encountered, representing close to 60% of cases. Despite advances in imaging and fixation, delayed diagnosis or treatment can still result in nonunion in 10%–15% of patients [1, 2]. Scaphoid nonunion is clinically important because it often leads to progressive carpal collapse, wrist pain, and ultimately degenerative arthritis if untreated [3]. Because the scaphoid receives its vascular supply primarily from distal to proximal, fractures involving the proximal pole are particularly vulnerable to avascular necrosis and delayed healing [4]. Treatment of scaphoid nonunion has evolved from nonvascularized bone grafting, such as the Russe technique [5], to vascularized grafting introduced in the late 20th century [6, 7]. Although vascularized bone grafts (VBGs) yield higher union rates in biologically compromised cases, they are technically demanding and may cause donor‐site morbidity [6, 8]. In parallel, advances in bone biology have introduced osteoinductive growth factors such as bone morphogenetic proteins (BMPs). Urist's landmark discovery of BMPs as autoinductive proteins revolutionized the understanding of bone healing [9]. Recombinant human BMP‐2 (rhBMP‐2) has been widely studied in long bone fractures and spinal fusion, with large randomized controlled trials demonstrating significantly accelerated bone healing [10]. Several systematic reviews have confirmed its effectiveness in promoting osteogenesis, though concerns regarding cost and potential complications remain [11, 12]. Hydroxyapatite (HA), as an osteoconductive scaffold, provides structural support and serves as a matrix for new bone formation [11, 13]. Combining osteoinductive factors such as BMP‐2 with HA carriers creates a synergistic composite substitute, which has shown reliable fusion in cases where autografts or vascularized grafts may be limited [14, 15, 16, 17]. NOVOSIS (rhBMP‐2 with HA carrier, commercially available composite) represents such a next‐generation bone graft substitute designed to combine osteoinductive and osteoconductive properties. Previous reports have demonstrated its efficacy in spinal fusion [14, 15], animal models of nonunion [17], and bone defect regeneration [18], and even in challenging long bone nonunions using the induced membrane technique and other reconstructive strategies [19, 20]. However, its application in carpal bones, particularly in the treatment of scaphoid nonunion, has not yet been systematically evaluated. Considering the biological challenges of scaphoid nonunion and the limitations of conventional grafting techniques, investigating the clinical applicability of NOVOSIS in this context is timely and warranted. Accordingly, the purposes of this study were as follows: to evaluate the rate of bony union and radiographic correction, including changes in lateral intrascaphoid angle (LISA) and scapholunate angle (SLA) following fixation combined with NOVOSIS in scaphoid waist nonunion; to evaluate the rate of bony union and radiographic correction, including changes in lateral intrascaphoid angle (LISA) and scapholunate angle (SLA) following fixation combined with NOVOSIS in scaphoid waist nonunion; to assess clinical outcomes, including pain, wrist function, range of motion, and grip strength after treatment; to assess clinical outcomes, including pain, wrist function, range of motion, and grip strength after treatment; to investigate the feasibility and potential advantages of NOVOSIS as a bone graft substitute, particularly in terms of avoiding donor‐site morbidity and simplifying the surgical procedure, and to explore its potential role in future clinical applications. to investigate the feasibility and potential advantages of NOVOSIS as a bone graft substitute, particularly in terms of avoiding donor‐site morbidity and simplifying the surgical procedure, and to explore its potential role in future clinical applications. We hypothesized that fixation combined with NOVOSIS would achieve reliable union, meaningful functional recovery, and restoration of carpal alignment while minimizing the morbidity associated with autologous bone grafting. Methods Study Design and Patients This retrospective review included seven consecutive patients with scaphoid waist nonunion treated at our institution between August 2023 and December 2024. During this period, NOVOSIS was selectively applied to patients with scaphoid waist nonunion who met the following conditions: (1) the patient refused autologous iliac bone graft due to donor‐site morbidity concerns; (2) the patient agreed to the use of NOVOSIS (0.5 mg recombinant human bone morphogenetic protein‐2 with hydroxyapatite carrier, commercially available composite) with additional cost coverage (approximately 1.5 million KRW [≈ USD 1100], not reimbursed by national insurance); and (3) fixation with two 2.3‐mm headless compression screws was considered technically feasible based on preoperative CT evaluation. Inclusion criteria were symptomatic scaphoid waist nonunion confirmed by radiographs and CT, patient consent for NOVOSIS application as above, age between 15 and 60 years, and a minimum follow‐up of 12 months. Exclusion criteria were acute fractures (< 3 months), pathological fractures, prior infection around the wrist, prior wrist fusion or advanced degenerative arthritis, severe avascular necrosis with collapse, previous multiple failed surgeries, systemic metabolic bone disease, or poor compliance with postoperative immobilization. Among all scaphoid waist nonunion cases treated during the study period, those who met the above criteria and completed follow‐up were included in the analysis. The mean interval from injury to surgery was 11.5 months (range, 6–18 months). All patients demonstrated radiographic and clinical findings consistent with established nonunion, without evidence of progressive healing on serial imaging prior to surgery. Patient demographics, mechanism of injury, and prior treatments were recorded. Surgical Technique All surgeries were performed by the senior author under regional or general anesthesia with tourniquet control. A representative case demonstrating this technique and postoperative course is shown in Figure 1. A standard volar approach through the flexor carpi radialis sheath was used in most cases. Fibrous tissue and sclerotic bone were debrided until punctate bleeding was observed. NOVOSIS was prepared according to the manufacturer's instructions: rhBMP‐2 solution was soaked into HA granules for 15 min before implantation. To correct humpback deformity, the HA granules were carefully impacted into the volar defect of the scaphoid waist to maximize contact with the host bone (Figure 2). A 57‐year‐old male slipped down 4 months prior and presented with left wrist pain. He was diagnosed with scaphoid waist nonunion and underwent fixation with two headless compression screws and NOVOSIS graft. (A) Initial wrist posteroanterior and lateral radiographs. (B) 3D CT scan showing humpback deformity. (C) Immediate postoperative radiograph. (D) Final follow‐up radiograph at 1 year and 3 months postoperatively. (E) Preoperative and postoperative CT scans demonstrating well‐incorporated hydroxyapatite (HA) granules within the union site. Intraoperative photographs showing preparation and application of the NOVOSIS graft. (A) Exposure of the scaphoid waist nonunion through a standard volar approach after debridement of fibrous and sclerotic bone. (B) NOVOSIS (rhBMP‐2–soaked hydroxyapatite granules) being gently impacted into the volar defect of the scaphoid waist. (C) Complete filling of the defect with HA granules, providing structural support and intimate contact with the host bone. According to the manufacturer's technical data (manufacturer's data sheet), NOVOSIS contains 0.5 mg of recombinant human BMP‐2 combined with 0.5 g of porous HA granules (total volume = 1.25 mL). As shown intraoperatively (Figure 2), the HA carrier has a three‐dimensionally interconnected porous structure (> 90% porosity) composed of irregular granules approximately 0.5–1 mm in diameter, designed for sustained rhBMP‐2 release and osteoconductive integration. Two guide wires were then inserted under fluoroscopic guidance, and two Arix headless compression screws (2.3 mm, standard commercial implant) were placed across the fracture line. No autologous bone graft or allograft was used. Wound closure was performed in layers (Figure 1). Postoperative Management Patients were immobilized in a short arm thumb‐spica splint for 6–8 weeks, with duration tailored to radiographic evidence of early healing. Progressive mobilization began at approximately 6 weeks, and strengthening was initiated between 10 and 12 weeks. Return to full activities was permitted only after solid union was confirmed radiographically. Outcome Measures Pain was assessed with the visual analogue scale (VAS, 0–10). Function was evaluated with the Mayo Wrist Score (MWS, 0–100). Grip strength was measured using a dynamometer and expressed as a percentage of the contralateral side. Wrist range of motion was measured with a goniometer. Clinical and radiographic evaluations were performed by the first author, who was not involved in the index surgeries. All radiologic assessments were independently reviewed by two fellowship‐trained hand surgeons, including the corresponding author, and final determinations were made by consensus. Radiographic Assessment Radiographs were obtained at 2, 6, and 12 weeks, and every 6 months thereafter. CT scans were performed immediately postoperatively, at 3 months postoperatively, or whenever bony union was clinically suspected, and again at the final follow‐up. The lateral intrascaphoid angle (LISA) and scapholunate angle (SLA) were measured preoperatively and at final follow‐up, as described by Nakamura et al. [21] and Schuind et al. [22]. Radiographic union was defined as continuous trabecular bridging across the fracture site in at least three cortices on biplanar radiographs and confirmed by CT in all cases. Clinical union required pain‐free wrist motion and absence of scaphoid tenderness. Statistical Analysis Normality was confirmed using the Shapiro–Wilk test. Paired t‐tests compared pre‐ and postoperative VAS, MWS, LISA, and SLA. Significance was set at p < 0.05. Statistical analysis was performed using SPSS v27 (IBM, Armonk, NY). This study was approved by the Institutional Review Board of our institution. All patients provided informed consent, and the study complied with the Declaration of Helsinki. Results Patient Demographics Seven patients (six male, one female) with a mean age of 30 years (range, 15–57) were included. The mechanisms of injury included motorcycle accident (n = 1), sports trauma (n = 1), occupational accident (n = 1), punching trauma (n = 3), and slip down (n = 1). The mean interval from injury to surgery was 11.5 months (range, 6–18 months), and the mean follow‐up duration was 12.4 months (range, 12–14 months) (Table 1). TABLE 1Patient demographics and baseline characteristics.PatientAge (years)SexMechanism of injuryInjury to OP time (M)Follow up period (M)152MMotorcycle accident1812222MSports trauma612330MOccupational accident812418FPunching trauma1013557MSlip down914619MPunching trauma1212715MPunching trauma1812Average3011.512.4 Patient demographics and baseline characteristics. Union and Complications All patients achieved union by the last follow‐up, with radiologic consolidation generally observed between 3 and 4 months postoperatively. There were no complications such as infection, screw loosening, heterotopic ossification, or donor site morbidity. One case received 2 HCS fixation with conventional auto‐iliac bone graft as the primary operation after 18 months of injury. However, screw loosening occurred after 9 months with persistent nonunion. The case underwent removal of the loosened screw and revision using NOVOSIS graft alone without additional autograft, achieving complete bony union within 6 months of reoperation (Figure 3). A 52‐year‐old male initially underwent fixation with two headless compression screws and conventional autologous iliac bone graft 18 months after injury. (A) Immediate postoperative radiograph following primary fixation. (B) Screw loosening observed at 9 months postoperatively with persistent nonunion at the fracture site. (C) Revision surgery using NOVOSIS graft after screw removal achieved complete bony union within 6 months. (D) Preoperative and postoperative CT scans showing incorporation of HA granules and bridging bone formation at the previous nonunion site. Clinical Outcomes VAS improved from 4.9 ± 1.2 preoperatively to 0.4 ± 0.8 postoperatively (p < 0.001). MWS improved from 59.3 ± 7.3 to 94.3 ± 5.4 (p < 0.001) (Table 4). The mean postoperative grip strength recovery was approximately 87.5% of the contralateral side, with 4 patients achieving 100% recovery, 1 patient within 75%–100%, and 2 patients within 50%–75%. The mean postoperative wrist range of motion recovery was approximately 89% of the contralateral side, with 3 patients achieving full recovery (100%), 3 patients in the 75%–99% range, and 1 patient in the 50%–74% range (Table 2). All patients reported satisfaction with pain relief and functional improvement. TABLE 4Mean values for clinical and radiologic outcomes.VariablePreoperationPostoperation p VAS4.86 ± 1.210.43 ± 0.792.0 × 10−5 MWS59.29 ± 7.3294.29 ± 5.351.1 × 10−4 LISA (°)51.7 ± 13.631.5 ± 5.10.007SLA (°)65.7 ± 6.852.2 ± 8.80.006 Note: Values are presented as mean ± standard deviation.Abbreviations: LISA, lateral intrascaphoid angle; MWS, Mayo wrist score; SLA, scapholunate angle; VAS, visual analogue scale. Mean values for clinical and radiologic outcomes. Note: Values are presented as mean ± standard deviation. Abbreviations: LISA, lateral intrascaphoid angle; MWS, Mayo wrist score; SLA, scapholunate angle; VAS, visual analogue scale. TABLE 2Clinical outcomes (VAS and Mayo Wrist Score).PatientVAS Pre‐opVAS Post‐opMWS Pre‐opMWS Post‐opROM (%)150558550–742606095100342659075–99450559575–99531709575–996605010010075060100100Abbreviations: MWS, mayo wrist score; VAS, visual analogue scale. Clinical outcomes (VAS and Mayo Wrist Score). Abbreviations: MWS, mayo wrist score; VAS, visual analogue scale. Radiographic Outcomes LISA improved from 51.7° ± 13.6° preoperatively to 31.5° ± 5.1° postoperatively (p = 0.007). SLA decreased from 65.7° ± 6.8° to 52.2° ± 8.8° (p = 0.006). Carpal alignment restoration was consistent across all cases (Table 3). A comprehensive summary of clinical and radiologic outcomes is presented in Table 4, and representative imaging findings are illustrated in Figure 4. TABLE 3Radiographic outcomes.PatientLISA Pre‐op (°)LISA Post‐op (°)SLA Pre‐op (°)SLA Post‐op (°)119.421.66957.9239.529.363.834.9358.23459.956.1450.838.755.848561.93172.456.2645.72676.863.5748.230.163.454.7Abbreviations: LISA, lateral intrascaphoid angle; SLA, scapholunate angle. Radiographic outcomes. Abbreviations: LISA, lateral intrascaphoid angle; SLA, scapholunate angle. Radiologic evaluation of carpal alignment. (A) Scapholunate angle (SLA): Preoperative versus postoperative. (B) Lateral intrascaphoid angle (LISA): Preoperative versus postoperative. Discussion In this preliminary clinical study, fixation combined with NOVOSIS achieved a 100% union rate in scaphoid waist nonunion, with substantial improvements in pain and wrist function. Significant correction of carpal alignment was observed, as demonstrated by improvements in the lateral intrascaphoid angle (LISA) and scapholunate angle (SLA). In addition, all patients recovered favorable wrist range of motion and grip strength without donor‐site morbidity or major complications. These findings suggest that NOVOSIS may provide both biological enhancement and structural support in the treatment of scaphoid nonunion. Main Clinical and Radiographic Outcomes The management of scaphoid nonunion remains one of the most debated areas in hand surgery because of the scaphoid's anatomical vascularity and biomechanical significance in wrist kinematics. Traditional bone grafting techniques such as corticocancellous inlay or wedge grafting achieved 70%–90% union rates but showed inconsistent results in biologically compromised cases, leading to the development of VBGs [6, 7]. VBGs have demonstrated high success rates in difficult scenarios such as proximal pole AVN, but their technical demands and donor‐site morbidity limit widespread use [6, 7, 8]. Although corticocancellous bone grafts harvested from the distal radius have been proposed as a less morbid alternative to iliac crest grafts, they are not entirely free of donor‐site complications. Extending the volar incision to obtain an adequate amount of cancellous bone can increase operative time and may cause local pain, tenderness, or sensory disturbance around the harvest site. Moreover, when rigid double‐screw fixation is required through a limited volar approach, the need for simultaneous bone harvesting can add surgical complexity. In this regard, using a ready‐to‐apply osteoinductive composite such as NOVOSIS can simplify the procedure while completely avoiding donor‐site morbidity. Nonvascularized grafts remain widely used in clinical practice, especially in cases without AVN. Kim et al. [23] demonstrated that nonvascularized bone grafting with rigid fixation yields reliable union in cases without AVN, whereas Malizos et al. [24] reported that vascularized grafts are particularly effective in biologically compromised cases. Thus, the decision between vascularized and nonvascularized grafts often depends on the presence of AVN, chronicity of nonunion, and surgeon expertise. Since Urist's discovery of bone morphogenetic proteins (BMPs), clinical studies such as Govender et al. have demonstrated the efficacy of recombinant human BMP‐2 (rhBMP‐2) in promoting bone healing in various orthopedic conditions [9, 10]. In our series, all seven patients achieved radiographic union, typically within 3–4 months after surgery. Pain relief and functional recovery were substantial, with VAS scores improving from 4.9 to 0.4 and Mayo Wrist Scores from 59.3 to 94.3. Carpal alignment was consistently restored, as reflected by correction of the lateral intrascaphoid angle from 51.7° to 31.5° and reduction of the scapholunate angle from 65.7° to 52.2°. Grip strength and wrist range of motion recovered to approximately 87%–89% of the contralateral side. These outcomes are favorable compared with historical nonvascularized graft techniques, which report union rates of 70%–90% but variable functional recovery and higher donor‐site morbidity [5, 23]. Biological Rationale and Biomechanical Implications Beyond achieving bony union, the long‐term biomechanical consequences of scaphoid nonunion should be considered. Untreated nonunion may lead to progressive carpal collapse and scaphoid nonunion advanced collapse (SNAC wrist), resulting in degenerative arthritis [25]. Restoration of carpal alignment is therefore important, as it may help re‐establish normal wrist kinematics and reduce degenerative progression. In our series, significant improvement in both the lateral intrascaphoid angle and scapholunate angle suggests that this technique contributes not only to union but also to biomechanical restoration. These findings are consistent with previous studies emphasizing the importance of early anatomical reconstruction and alignment restoration to prevent long‐term functional deterioration [26]. Clinical Indications and Comparison With Conventional Grafting In addition, the indications and limitations of NOVOSIS should be considered in clinical practice. In the present study, this technique was selectively applied to scaphoid waist nonunion cases without severe avascular necrosis or advanced collapse, where stable fixation could be achieved. Therefore, its applicability may be limited in cases with significant deformity, long‐standing nonunion, or compromised vascularity. Compared with traditional nonvascularized bone grafting and vascularized bone graft techniques, NOVOSIS offers the advantage of avoiding donor‐site morbidity and simplifying the surgical procedure. However, vascularized grafts may still be more appropriate in biologically compromised cases such as proximal pole AVN. From an economic perspective, the cost of a 0.5 mg NOVOSIS product is approximately USD 1100, which is relatively high; however, the potential benefits of reduced operative time, avoidance of donor‐site complications, and faster rehabilitation may partially offset these costs in selected cases. Hydroxyapatite (HA) is widely regarded as a dependable osteoconductive scaffold, supporting cellular migration and facilitating new bone formation [13]. Dorozhkin has emphasized its excellent biocompatibility and ability to integrate with host tissue, making it suitable as a structural matrix [13]. More recently, translational studies have explored composite grafts that combine osteoconductive scaffolds with osteoinductive molecules. NOVOSIS, a preparation consisting of rhBMP‐2 embedded within HA granules, represents such an approach. Experimental work in rodent models of nonunion and spinal fusion demonstrated faster callus formation and stronger biomechanical stability [16, 17]. Clinical investigations in spinal fusion also showed higher rates of radiographic consolidation without major safety issues [14, 15]. Moreover, NOVOSIS has demonstrated promising outcomes in clinical series of long bone nonunions, including the induced membrane technique and large bone defect reconstructions [19, 20]. These data indicate that the synergistic interaction between rhBMP‐2 and HA may be effective not only in spinal and long bone applications but also in small carpal bones such as the scaphoid. The present study extends these findings by demonstrating their clinical applicability in scaphoid nonunion. Of particular note, one patient in our series had previously undergone conventional iliac crest bone grafting with 2 headless compression screws fixation, which failed due to persistent nonunion and 1 screw loosening. Following the screw removal and revision with NOVOSIS graft alone without additional autograft, complete union was achieved within 6 months. This unique case underscores the potential of rhBMP‐2/HA composites not only as a primary adjunct to fixation but also as a revision in recalcitrant nonunions where traditional grafting has failed. The current study builds upon these advances by evaluating the integration of NOVOSIS in scaphoid nonunion surgery. Our results demonstrated significant radiologic correction of carpal alignment and meaningful improvements in pain and wrist function. Compared to historical series using traditional nonvascularized grafts, our union rates and functional outcomes appear favorable [5, 23]. While long‐term data are required, the early results suggest that combining structural stability with biologic enhancement can address the dual challenges of mechanical instability and impaired biology in scaphoid nonunion. Limitations and Future Directions This preliminary clinical series, although limited by a small sample size, provides early clinical evidence supporting the clinical utility of NOVOSIS as a bone graft substitute for scaphoid nonunion. Larger, controlled studies are warranted to validate these findings and to establish standardized indications. Limitations of our study include the retrospective design, small sample size (n = 7), and relatively short follow‐up, which may underestimate late complications such as collapse or degenerative progression. Moreover, the absence of a control group limits the ability to definitively attribute outcomes to NOVOSIS itself. Nevertheless, the consistency of our results with prior preclinical and spinal fusion studies [14, 15, 16, 17, 18] strengthens the biological plausibility of our findings. Although the material cost of NOVOSIS (approximately USD 1100 for a 0.5 mg product) is higher than that of conventional cancellous grafting, the avoidance of donor‐site morbidity, reduced operative time, and faster rehabilitation could justify the expense in selected cases. Future multicenter, prospective trials are warranted to validate the role of rhBMP‐2/HA composites in the upper extremity. In conclusion, scaphoid nonunion remains a complex clinical challenge. Conventional techniques have demonstrated variable success, especially in cases complicated by AVN. The integration of biologics such as BMP‐2 with HA scaffolds offers a promising strategy to augment the healing environment. Our early results using NOVOSIS suggest that this composite material can enhance radiographic healing and functional outcomes. With further clinical validation, this approach has the potential to expand the reconstructive method for difficult scaphoid nonunions. Conclusion This preliminary clinical study demonstrated 100% union, significant pain relief, functional recovery, and radiographic correction in scaphoid waist nonunion without donor‐site morbidity. These findings indicate that NOVOSIS (rhBMP‐2–soaked hydroxyapatite) grafting is a technically simple and biologically feasible alternative to autologous bone grafting. Although limited by the small sample size and short‐term follow‐up, this study provides preliminary clinical evidence supporting the potential role of rhBMP‐2/HA composite grafting in small‐bone nonunion. Further prospective, controlled studies are warranted to validate its long‐term safety and efficacy. Author Contributions Jisu Park: data curation, writing – original draft, conceptualization, methodology. Hyung Joon Ahn: investigation, data curation. Ki Youn Kwon: investigation, data curation. Jin‐Rok Oh: conceptualization, writing – review and editing, supervision. Funding The authors have nothing to report. Disclosure All authors meet the criteria for authorship according to the ICMJE guidelines. All authors contributed substantially to the conception, design, analysis, and interpretation of data, drafted or critically revised the manuscript, approved the final version, and agree to be accountable for all aspects of the work. Ethics Statement This study was approved by the Institutional Review Board of our institution. Consent Written informed consent was obtained from all participants. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgments The authors have nothing to report. Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. References Associated Data Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.